Molecular Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, a

Molecular Diagnostics Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Area (Oncology, Infectious Disease, Genetic Testing, Cardiac Diseases, Immune System Disorders, and Others), Technology (Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next-Generation Sequencing, DNA Microarrays, In-Situ Hybridization, and Others), Product & Services (Assays & Kits, Instruments, and Services & Software), End User (Hospitals & Clinics, Diagnostic Laboratories, Research & Academic Institutes, and Others), and Geography


The molecular diagnostics market size is expected to reach US$ 45,875.65 million by 2030 from US$ 18,173.87 million in 2022; it is estimated to register a CAGR of 12.3% from 2022 to 2030. The report highlights trends prevailing in the market and the factors driving and hindering the molecular diagnostics market growth. The growth of the market is attributed to the development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases. However, limitations associated with molecular testing hinders the market growth.

Molecular Diagnostics in Personalized Medicine for Molecular Diagnostics Market Growth in the Upcoming Years

With progress in high-throughput techniques, genome research has become more convenient and cost effective. Molecular diagnostics is becoming increasingly indispensable in clinical laboratories as these kits and tests provide rapid detection results as opposed to the conventional tests, which also involved culturing microbes in laboratory conditions in some cases. Using precision medicine, medical treatments and interventions are tailored to each patient based on their unique genetic makeup, lifestyle, and environment. Molecular diagnostics plays an important role in this approach, as it enables the identification of specific biomarkers, genetic mutations, and gene expression patterns that impact decision-making related to the treatment of patients. Drug development has become increasingly dependent on molecular diagnostics. A wide range of molecular imaging techniques are used in screening, detecting, diagnosing, treating, and assessing heterogeneity; making progression plans; examining molecular characteristics; and monitoring patient outcomes. In addition, molecular imaging can aid in the detection of tiny tumors and assessment of their activities, contributing significantly to the development and expansion of personalized medicine, research, clinical trials, and medical practice in oncology. A high-throughput genotyping platform can be used to detect genetic aberrations in clinical samples, and next-generation sequencing can be used to identify all types of cancer-causing changes. The introduction of these techniques into clinical practice would enable the identification of molecular targets in each patient, along with facilitating the tracking of the molecular progression of diseases. With these approaches, cancer patients will be able to receive personalized medicine. Thus, with technology ever evolving, the market for molecular diagnostics seems to have a bright future.

Limitations Associated with Molecular Testing Hampers the Market Growth

The outcomes of molecular testing depend on sampling and testing processes, technicians’ skill sets, etc., which may lead to variations in test results. Further, some test procedures take longer for producing results. Several times, test kits may show false positive or negative results. Thus, uncertainties associated with molecular tests hamper their adoption, especially in diagnostics and treatment of life-threatening diseases. The limited awareness of point-of-care tests, particularly in developing and underdeveloped countries, also hinders the market growth. In addition, the cost of molecular testing for indications such as cancer and viral infections, and the shortage of supplies are hampering the molecular diagnostics market.

Molecular Diagnostics Market, By Disease Area Insights

Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others.


The infectious disease segment held the largest market share in 2022. However, oncology segment is anticipated to register the highest CAGR of 12.6% during the forecast period. Oncology molecular diagnostics are tests that expose inherited material, proteins, associated molecules and assess metabolic functions, drug metabolism, and disease induction grounded on DNA, RNA, and proteins that deliver oncological information. As stated by World Health Organization (WHO), cancer reckoned for roughly 10 million demises in 2020. Furthermore, as per the 2021 statistics by the American Cancer Society, by 2040, the global burden of carcinoma is anticipated to raise to 27.5 million fresh cases and 16.3 million cancer deceases. Such like high figures denote that the evaluated rising frequency of cancer is chipping into the accelerating requirement for primitive diagnosis and preventive cure. There are numerous methods to diagnose carcinoma comprehending PCR, INAAT, and NGS etc. Among all the conception of PCR (polymerase chain reaction) led to an enormous advancement in clinical DNA testing. PCR-based methodologies demand straightforward instrumentation and infrastructure, exploit only minute quantities of biological material and are extensively harmonious with clinical routine.

Although the cost of PCR is lofty, most accurate real-time PCR approach (with more than 99% accuracy) is the one substantially used in numerous developed countries including Korea, while developing countries substantially exploit the conventional PCR (more than 90% accuracy), which is affordable than real-time PCR. Because of the high prices of the other options, underdeveloped countries generally use Rapid PCR (60 – 70% accuracy). Within the field of oncology molecular diagnostics, NGS is another technology flaunting the loftiest rate of growth. Numerous companies are working intensely to make economic use of this technology. For instance, in April 2021, Illumina Inc. blazoned its partnership with Kartos Therapeutics to co-develop an NGS- Based TP53 Companion Diagnostic, which aided to reduce the costs associated with storing and managing of genomic data.

Molecular Diagnostics Market, By Technology-Based Insights

Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. The PCR is further sub segmented into RT-PCR, qPCR, Multiplex PCR, and others. The PCR segment held the largest share of the market in 2022, and the same segment is anticipated to register the highest CAGR of 12.7% in the market during the forecast period. PCR is mainly used to make or amplify DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. This technique is widely used in various application such as functional analysis of genes, diagnosis of hereditary, DNA cloning, paternity testing, detection of infectious diseases, and forensic sciences. Polymerase chain reaction has been classified into traditional PCR, real-time PCR, and digital PCR. However, ongoing technological advances and surging demand amid the pandemic will continue to fuel the need for PCR tests in India as well as other Asia Pacific countries. Consistent prevalence of diseases like tuberculosis, Hepatitis, flu, and serious infections will foster PoC molecular diagnostic industry trends. Presently, the outbreak of novel COVID-19 pandemic would create lucrative growth aspects for the market as this approach is highly critical to detect virus in individuals who exhibit no symptoms of signs of disease. PCR’s exquisite sensitivity, relative simplicity, and cost-effectiveness makes PCR stand apart from other nucleic acid amplification techniques, cementing it as a mainstay in molecular laboratories. PCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of Digital PCR (dPCR) techniques. dPCR has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories.During pandemic outbreak, one of the first mover startup, Mylab PathoDetect COVID-19 Qualitative PCR kit was among the first in the country to receive commercial approval from the Central Drugs Standard Control Organisation (CDSCO) last year. Following the approval, Mylab had partnered with biotech giant Serum Institute of India and local firm AP Globale. PCR is further sub-segmented into RT-PCR, qPCR, multiplex PCR and others. Molecular Diagnostics Market, By Purchase Mode-Based Insights.

Based on product & services, the molecular diagnostics market is segmented into assays & kits, instruments, and services & software. The assays and kits segment are held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during the forecast period. Molecular Diagnostics assays are among the widely used technique for analysis. Various types of assays such as rapid molecular assays, reverse transcription-polymerase chain reaction (RT-PCR), antigens, and others are used to identify and analyze various diseases such as influenza COVID 19, tuberculosis, and others. As part of product innovation and business strategies, the market players offer diagnostic kits for different test kits. The regional players are actively involved in business development related to the segment. For instance, In September 2021, Mylab Discovery Solutions acquired a majority stake in Sanskritech, developer of a platform Swayam a point of care testing system that can perform about 70 tests on the point. Moreover, in the COVID19 pandemic, various global market players offer their kits through their regional business divisions. Based on the above factors, the segment is expected to contribute remarkably during the forecast period.

Based on end user, the molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and others. In 2022, the diagnostic laboratories segment held the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 12.7% during 2022 to 2030, owing to the rise in the detection and diagnosis of various medical conditions across the regions. Diagnostic laboratories are the primary uses for molecular diagnostics products and services. It has well-established facilities as per the regulatory requirements. The laboratories use all possible molecular diagnostic products and services. The sample collected from the patients is analyzed and studied using different instruments, reagents, methods, and technologies. The labs provide services to hospitals, clinics, at-home care, and others. The increasing prevalence of chronic diseases, infectious diseases, outsourcing the molecular diagnostics activities by individual researchers are among the factors supporting the segment growth during the forecast period.

Molecular Diagnostics Market: Competitive Landscape and Key Developments

Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc, F. Hoffman-La Roche Ltd., Qiagen NV, bioMerieux SA, Illumnia Inc., Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are among the leading companies operating in the molecular diagnostics market.

Market players are launching new products to the market. Below are few instances:

In January 2023, Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test. The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Washington.
In July 2023, Thermo Fisher launched new software for molecular diagnostics labs. This software helps in streamlining routine diagnostics testing for standardization and rapid time-to-results. It can enhance the potential of a lab to dynamically respond to quickly changing testing environments by connecting workflow steps within a single interface.
In October 2021, Agilent Technologies Inc. has announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio (abemaciclib) in combination with endocrine therapy.


1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Molecular Diagnostics Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South & Central America PEST Analysis
4.2.5 Middle East & Africa PEST Analysis
5. Molecular Diagnostics Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
5.1.2 Surging Prevalence of Associated Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Molecular Testing
5.3 Market Opportunities
5.3.1 Advancements in Molecular Diagnostics Technologies
5.4 Future Trends
5.4.1 Molecular Diagnostics in Personalized Medicine
5.5 Impact Analysis:
6. Molecular Diagnostics Market - Global Market Analysis
6.1 Molecular Diagnostics Market Revenue (US$ Mn), 2022 – 2030
7. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Disease Area
7.1 Overview
7.2 Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Infectious Disease
7.4.1 Overview
7.4.2 Infectious Disease: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Genetic Testing
7.5.1 Overview
7.5.2 Genetic Testing: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Cardiac Diseases
7.6.1 Overview
7.6.2 Cardiac Diseases: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Immune System Disorders
7.7.1 Overview
7.7.2 Immune System Disorders: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Others
7.8.1 Overview
7.8.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Technology
8.1 Overview
8.2 Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 RT-PCR
8.3.2.1.1 Overview
8.3.3 RT-PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.3.1 qPCR
8.3.3.1.1 Overview
8.3.4 PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.4.1 Multiplex PCR
8.3.4.1.1 Overview
8.3.5 Multiplex PCR: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3.5.1 Others
8.3.5.1.1 Overview
8.3.6 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
8.5.1 Overview
8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 DNA Microarrays
8.6.1 Overview
8.6.2 DNA Microarrays: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 In-Situ Hybridization (ISH)
8.7.1 Overview
8.7.2 In-Situ Hybridization (ISH): Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by Product and Services
9.1 Overview
9.2 Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
9.3 Assays and Kits
9.3.1 Overview
9.3.2 Assays and Kits: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Instruments
9.4.1 Overview
9.4.2 Instruments: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Services and Software
9.5.1 Overview
9.5.2 Services and Software: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10. Global Molecular Diagnostics Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Diagnostics Laboratories
10.4.1 Overview
10.4.2 Diagnostics Laboratories: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11. Molecular Diagnostics Market - Geographical Analysis
11.1 North America Molecular Diagnostics Market, Revenue And Forecast To 2030
11.1.1 Overview
11.1.2 North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3 North America Molecular Diagnostics Market, by Disease Area
11.1.4 North America Molecular Diagnostics Market, by Technology
11.1.4.1 North America Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
11.1.5 North America Molecular Diagnostics Market, by Product and Services
11.1.6 North America Molecular Diagnostics Market, by End User
11.1.6.1 North America Molecular Diagnostics Market, by Country
11.1.7 US
11.1.7.1 Overview
11.1.8 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.9 US Molecular Diagnostics Market, by Disease Area
11.1.10 US Molecular Diagnostics Market, by Technology
11.1.10.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
11.1.11 US Molecular Diagnostics Market, by Product and Services
11.1.12 US Molecular Diagnostics Market, by End User
11.1.13 Canada
11.1.13.1 Overview
11.1.14 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.15 Canada Molecular Diagnostics Market, by Disease Area
11.1.16 Canada Molecular Diagnostics Market, by Technology
11.1.16.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.17 Canada Molecular Diagnostics Market, by Product and Services
11.1.18 Canada Molecular Diagnostics Market, by End User
11.1.19 Mexico
11.1.19.1 Overview
11.1.20 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.1.21 Mexico Molecular Diagnostics Market, by Disease Area
11.1.22 Mexico Molecular Diagnostics Market, by Technology
11.1.22.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.1.23 Mexico Molecular Diagnostics Market, by Product and Services
11.1.24 Mexico Molecular Diagnostics Market, by End User
11.2 Europe Molecular Diagnostics Market, Revenue And Forecast to 2030
11.2.1 Overview
11.2.2 Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.3 Europe Molecular Diagnostics Market, by Disease Area
11.2.4 Europe Molecular Diagnostics Market, by Technology
11.2.4.1 Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.5 Europe Molecular Diagnostics Market, by Product and Services
11.2.6 Europe Molecular Diagnostics Market, by End User
11.2.6.1 Europe Molecular Diagnostics Market by Country
11.2.7 Germany
11.2.7.1 Overview
11.2.8 Germany Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.9 Germany Molecular Diagnostics Market, by Disease Area
11.2.10 Germany Molecular Diagnostics Market, by Technology
11.2.10.1 Germany Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.11 Germany Molecular Diagnostics Market, by Product and Services
11.2.12 Germany Molecular Diagnostics Market, by End User
11.2.13 UK
11.2.13.1 Overview
11.2.14 UK Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.15 UK Molecular Diagnostics Market, by Disease Area
11.2.16 UK Molecular Diagnostics Market, by Technology
11.2.16.1 UK Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.17 UK Molecular Diagnostics Market, by Product and Services
11.2.18 UK Molecular Diagnostics Market, by End User
11.2.19 France
11.2.19.1 Overview
11.2.20 France Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.21 France Molecular Diagnostics Market, by Disease Area
11.2.22 France Molecular Diagnostics Market, by Technology
11.2.22.1 France Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.23 France Molecular Diagnostics Market, by Product and Services
11.2.24 France Molecular Diagnostics Market, by End User
11.2.25 Italy
11.2.25.1 Overview
11.2.26 Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.27 Italy Molecular Diagnostics Market, by Disease Area
11.2.28 Italy Molecular Diagnostics Market, by Technology
11.2.28.1 Italy Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.29 Italy Molecular Diagnostics Market, by Product and Services
11.2.30 Italy Molecular Diagnostics Market, by End User
11.2.31 Spain
11.2.31.1 Overview
11.2.32 Spain Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.33 Spain Molecular Diagnostics Market, by Disease Area
11.2.34 Spain Molecular Diagnostics Market, by Technology
11.2.34.1 Spain Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.34.1.1 Spain Molecular Diagnostics Market, by Product and Services
11.2.35 Spain Molecular Diagnostics Market, by End User
11.2.36 Rest of Europe
11.2.36.1 Overview
11.2.37 Rest of Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.2.38 Rest of Europe Molecular Diagnostics Market, by Disease Area
11.2.39 Rest of Europe Molecular Diagnostics Market, by Technology
11.2.39.1 Rest of Europe Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.2.40 Rest of Europe Molecular Diagnostics Market, by Product and Services
11.2.41 Rest of Europe Molecular Diagnostics Market, by End User
11.3 Asia Pacific Molecular Diagnostics Market, Revenue And Forecast to 2030
11.3.1 Overview
11.3.2 Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.3 Asia Pacific Molecular Diagnostics Market, by Disease Area
11.3.4 Asia Pacific Molecular Diagnostics Market, by Technology
11.3.4.1 Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.5 Asia Pacific Molecular Diagnostics Market, by Product and Services
11.3.6 Asia Pacific Molecular Diagnostics Market, by End User
11.3.6.1 Asia Pacific Molecular Diagnostics Market by Country
11.3.7 China
11.3.7.1 Overview
11.3.8 China Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.9 China Molecular Diagnostics Market, by Disease Area
11.3.10 China Molecular Diagnostics Market, by Technology
11.3.10.1 China Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.11 China Molecular Diagnostics Market, by Product and Services
11.3.12 China Molecular Diagnostics Market, by End User
11.3.13 Japan
11.3.13.1 Overview
11.3.14 Japan Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.15 Japan Molecular Diagnostics Market, by Disease Area
11.3.16 Japan Molecular Diagnostics Market, by Technology
11.3.16.1 Japan Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.17 Japan Molecular Diagnostics Market, by Product and Services
11.3.18 Japan Molecular Diagnostics Market, by End User
11.3.19 India
11.3.19.1 Overview
11.3.20 India Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.21 India Molecular Diagnostics Market, by Disease Area
11.3.22 India Molecular Diagnostics Market, by Technology
11.3.22.1 India Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.23 India Molecular Diagnostics Market, by Product and Services
11.3.24 India Molecular Diagnostics Market, by End User
11.3.25 Australia
11.3.25.1 Overview
11.3.26 Australia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.27 Australia Molecular Diagnostics Market, by Disease Area
11.3.28 Australia Molecular Diagnostics Market, by Technology
11.3.28.1 Australia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.29 Australia Molecular Diagnostics Market, by Product and Services
11.3.30 Australia Molecular Diagnostics Market, by End User
11.3.31 South Korea
11.3.31.1 Overview
11.3.32 South Korea Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.33 South Korea Molecular Diagnostics Market, by Disease Area
11.3.34 South Korea Molecular Diagnostics Market, by Technology
11.3.34.1 South Korea Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.35 South Korea Molecular Diagnostics Market, by Product and Services
11.3.36 South Korea Molecular Diagnostics Market, by End User
11.3.37 Singapore
11.3.37.1 Overview
11.3.38 Singapore Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.39 Singapore Molecular Diagnostics Market, by Disease Area
11.3.40 Singapore Molecular Diagnostics Market, by Technology
11.3.40.1 Singapore Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.41 Singapore Molecular Diagnostics Market, by Product and Services
11.3.42 Singapore Molecular Diagnostics Market, by End User
11.3.43 Malaysia
11.3.43.1 Overview
11.3.44 Malaysia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.45 Malaysia Molecular Diagnostics Market, by Disease Area
11.3.46 Malaysia Molecular Diagnostics Market, by Technology
11.3.46.1 Malaysia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.47 Malaysia Molecular Diagnostics Market, by Product and Services
11.3.48 Malaysia Molecular Diagnostics Market, by End User
11.3.49 Philippines
11.3.49.1 Overview
11.3.50 Philippines Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.51 Philippines Molecular Diagnostics Market, by Disease Area
11.3.52 Philippines Molecular Diagnostics Market, by Technology
11.3.52.1 Philippines Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.53 Philippines Molecular Diagnostics Market, by Product and Services
11.3.54 Philippines Molecular Diagnostics Market, by End User
11.3.55 Thailand
11.3.55.1 Overview
11.3.56 Thailand Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.57 Thailand Molecular Diagnostics Market, by Disease Area
11.3.58 Thailand Molecular Diagnostics Market, by Technology
11.3.58.1 Thailand Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.59 Thailand Molecular Diagnostics Market, by Product and Services
11.3.60 Thailand Molecular Diagnostics Market, by End User
11.3.61 Indonesia
11.3.61.1 Overview
11.3.62 Indonesia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.63 Indonesia Molecular Diagnostics Market, by Disease Area
11.3.64 Indonesia Molecular Diagnostics Market, by Technology
11.3.64.1 Indonesia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.65 Indonesia Molecular Diagnostics Market, by Product and Services
11.3.66 Indonesia Molecular Diagnostics Market, by End User
11.3.67 Vietnam
11.3.67.1 Overview
11.3.68 Vietnam Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.69 Vietnam Molecular Diagnostics Market, by Disease Area
11.3.70 Vietnam Molecular Diagnostics Market, by Technology
11.3.70.1 Vietnam Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.71 Vietnam Molecular Diagnostics Market, by Product and Services
11.3.72 Vietnam Molecular Diagnostics Market, by End User
11.3.73 Rest of Asia Pacific
11.3.73.1 Overview
11.3.74 Rest of Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.3.75 Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area
11.3.76 Rest of Asia Pacific Molecular Diagnostics Market, by Technology
11.3.76.1 Rest of Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.3.77 Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services
11.3.78 Rest of Asia Pacific Molecular Diagnostics Market, by End User
11.4 Middle East & Africa Molecular Diagnostics Market, Revenue And Forecast to 2030
11.4.1 Overview
11.4.2 Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.3 Middle East & Africa Molecular Diagnostics Market, by Disease Area
11.4.4 Middle East & Africa Molecular Diagnostics Market, by Technology
11.4.4.1 Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.5 Middle East & Africa Molecular Diagnostics Market, by Product and Services
11.4.6 Middle East & Africa Molecular Diagnostics Market, by End User
11.4.6.1 Middle East & Africa Molecular Diagnostics Market by Country
11.4.7 UAE
11.4.7.1 Overview
11.4.8 UAE Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.9 UAE Molecular Diagnostics Market, by Disease Area
11.4.10 UAE Molecular Diagnostics Market, by Technology
11.4.10.1 UAE Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.11 UAE Molecular Diagnostics Market, by Product and Services
11.4.12 UAE Molecular Diagnostics Market, by End User
11.4.13 Saudi Arabia
11.4.13.1 Overview
11.4.14 Saudi Arabia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.15 Saudi Arabia Molecular Diagnostics Market, by Disease Area
11.4.16 Saudi Arabia Molecular Diagnostics Market, by Technology
11.4.16.1 Saudi Arabia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.17 Saudi Arabia Molecular Diagnostics Market, by Product and Services
11.4.18 Saudi Arabia Molecular Diagnostics Market, by End User
11.4.19 South Africa
11.4.19.1 Overview
11.4.20 South Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.21 South Africa Molecular Diagnostics Market, by Disease Area
11.4.22 South Africa Molecular Diagnostics Market, by Technology
11.4.22.1 South Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.23 South Africa Molecular Diagnostics Market, by Product and Services
11.4.24 South Africa Molecular Diagnostics Market, by End User
11.4.25 Rest of Middle East & Africa
11.4.25.1 Overview
11.4.26 Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.4.27 Rest of Middle East & Africa Molecular Diagnostics Market, by Disease Area
11.4.28 Rest of Middle East & Africa Molecular Diagnostics Market, by Technology
11.4.28.1 Rest of Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.4.29 Rest of Middle East & Africa Molecular Diagnostics Market, by Product and Services
11.4.30 Rest of Middle East & Africa Molecular Diagnostics Market, by End User
11.5 South & Central America Molecular Diagnostics Market, Revenue And Forecast to 2030
11.5.1 Overview
11.5.2 South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.3 South & Central America Molecular Diagnostics Market, by Disease Area
11.5.4 South & Central America Molecular Diagnostics Market, by Technology
11.5.4.1 South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.5 South & Central America Molecular Diagnostics Market, by Product and Services
11.5.6 South & Central America Molecular Diagnostics Market, by End User
11.5.6.1 South & Central America Molecular Diagnostics Market by Country
11.5.7 Brazil
11.5.7.1 Overview
11.5.8 Brazil Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.9 Brazil Molecular Diagnostics Market, by Disease Area
11.5.10 Brazil Molecular Diagnostics Market, by Technology
11.5.10.1 Brazil Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.11 Brazil Molecular Diagnostics Market, by Product and Services
11.5.12 Brazil Molecular Diagnostics Market, by End User
11.5.13 Argentina
11.5.13.1 Overview
11.5.14 Argentina Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.15 Argentina Molecular Diagnostics Market, by Disease Area
11.5.16 Argentina Molecular Diagnostics Market, by Technology
11.5.16.1 Argentina Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.17 Argentina Molecular Diagnostics Market, by Product and Services
11.5.18 Argentina Molecular Diagnostics Market, by End User
11.5.19 Rest of South & Central America
11.5.19.1 Overview
11.5.20 Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
11.5.21 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
11.5.22 Rest of South & Central America Molecular Diagnostics Market, by Technology
11.5.22.1 Rest of South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
11.5.23 Rest of South & Central America Molecular Diagnostics Market, by Product and Services
11.5.24 Rest of South & Central America Molecular Diagnostics Market, by End User
12. Pre & Post Covid-19 Impact
12.1 Pre & Post Covid-19 Impact
13. Molecular Diagnostics Market Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Molecular Diagnostics Market, Key Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Agilent Technologies Inc
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Thermo Fisher Scientific Inc
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 F. Hoffmann-La Roche Ltd
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Qiagen NV
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 bioMerieux SA
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Illumina Inc
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Siemens Healthineers AG
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Novartis AG
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
14.11 TBG Diagnostics Limited
14.11.1 Key Facts
14.11.2 Business Description
14.11.3 Products and Services
14.11.4 Financial Overview
14.11.5 SWOT Analysis
14.11.6 Key Developments
15. Appendix
15.1 About Us
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Molecular Diagnostics Market Segmentation
Table 2. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 3. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 4. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 5. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 6. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 7. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 8. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 9. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 10. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 11. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 12. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 13. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 14. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 15. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 16. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 17. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 18. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 19. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 20. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 21. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 22. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 23. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 24. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 25. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 26. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – End User
Table 27. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Disease Area
Table 28. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 29. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 30. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 31. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 32. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 33. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 34. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 35. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 36. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 37. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 38. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 39. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 40. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 41. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 42. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 43. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 44. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 45. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 46. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – End User
Table 47. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) – Disease Area
Table 48. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Technology
Table 49. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Polymerase Chain Reaction (PCR)
Table 50. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) – Product and Services
Table 51. Sp

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings